Becton, Dickinson and Company (BDX)
BDX Stock Gains Following Q4 Earnings Beat and Higher Margins
BD's overall topline in the fourth quarter of fiscal 2024 benefits from revenue growth in all segments.
Becton Dickinson (BDX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Becton Dickinson (BDX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Becton Dickinson (BDX) Q4 Earnings and Revenues Surpass Estimates
Becton Dickinson (BDX) came out with quarterly earnings of $3.81 per share, beating the Zacks Consensus Estimate of $3.77 per share. This compares to earnings of $3.42 per share a year ago.
Becton Dickinson beats quarterly estimates on strength in drug-delivery devices
Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices.
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
Strong Growth and Margin Execution Drives Performance in Quarter Q4 revenue of $5.4 billion increased 6.9% as reported, 7.4% currency-neutral and 6.2% organic Q4 GAAP and adjusted diluted EPS from continuing operations of $1.45 and $3.81 grew 173.6% and 11.4%, respectively FY24 revenue of $20.2 billion increased 4.2% as reported and currency neutral, 4.6% adjusted currency-neutral, and 5.0% organic FY24 GAAP and adjusted diluted EPS from continuing operations of $5.93 and $13.14 grew 16.3% and 7.6%, respectively FY24 cash from continuing operations grew 28.5% to $3.8 billion and Free Cash Flow grew 47.4% to $3.1 billion, increasing $0.9 billion and $1.0 billion since the prior year, respectively Company issues FY25 revenue guidance including GAAP growth of 8.9% to 9.4%, adjusted currency-neutral growth of 8.8% to 9.3% and organic growth of 4.0% to 4.5% Company issues FY25 adjusted diluted EPS guidance of $14.25 to $14.60 1, which reflects growth of about 10% at the midpoint FRANKLIN LAKES, N.J. , Nov. 7, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2024 fourth quarter and full year which ended September 30, 2024.
BD Board Increases Dividend for 53rd Consecutive Year
FRANKLIN LAKES, N.J. , Nov. 7, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, an increase of 9.5% from the previous quarter.
Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings?
Continued solid uptake of BD's products is expected to have driven fiscal fourth-quarter revenues.
Insights Into Becton Dickinson (BDX) Q4: Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Becton, Dickinson And HP Among 13 Companies To Announce Annual Dividend Increases In First Half Of November
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. I expect 13 companies to announce their annual increases in the first half of November, including double-digit increases from Automatic Data Processing, Roper Technologies, and Snap-on. Investors saw good 10%+ increases from insurer Brown & Brown, payment processor Visa, and specialty chemical company RPM in October.
BDX Stock Declines Despite Launching BD IO Vascular Access System
BD announces the BD Intraosseous Vascular Access System to enable quick vascular access for critical care situations.
Becton Dickinson (BDX) Earnings Expected to Grow: Should You Buy?
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Becton Dickinson (BDX) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
